These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Low-molecular-weight heparins versus unfractionated heparin for treatment of hemodialysed patients]. Kes P; Basić-Jukić N; Jurić I Lijec Vjesn; 2007; 129(8-9):305-8. PubMed ID: 18198633 [No Abstract] [Full Text] [Related]
5. 'Heparin rebound' means the opposite in cardiac surgery (bleeding) and in cardiology (thrombosis). Koracevic G Blood Coagul Fibrinolysis; 2010 Mar; 21(2):198-9. PubMed ID: 20118712 [No Abstract] [Full Text] [Related]
6. Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged? Fareed J; Iqbal O; Cunanan J; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Int Angiol; 2008 Jun; 27(3):176-92. PubMed ID: 18506123 [TBL] [Abstract][Full Text] [Related]
7. The use of unfractionated heparin and low molecular weight heparins in pregnancy. Casele HL Clin Obstet Gynecol; 2006 Dec; 49(4):895-905. PubMed ID: 17082684 [TBL] [Abstract][Full Text] [Related]
9. Heparins in the new millennium: will unfractionated heparin survive? Epilogue. Fareed J; Hoppensteadt DA Semin Thromb Hemost; 2000; 26 Suppl 1():87-8. PubMed ID: 11011812 [No Abstract] [Full Text] [Related]
10. Heparin and low molecular weight heparin in thrombosis and beyond. Mousa SA Curr Opin Investig Drugs; 2002 Aug; 3(8):1181-6. PubMed ID: 12211411 [TBL] [Abstract][Full Text] [Related]
11. The safety and usefulness of low molecular weight heparins and unfractionated heparins in patients with acute stroke. Kiphuth IC; Köhrmann M; Huttner HB; Schellinger PD Expert Opin Drug Saf; 2009 Sep; 8(5):585-97. PubMed ID: 19614560 [TBL] [Abstract][Full Text] [Related]
12. Survival of heparins, oral anticoagulants, and aspirin after the year 2010. Fareed J; Hoppensteadt DA; Fareed D; Demir M; Wahi R; Clarke M; Adiguzel C; Bick R Semin Thromb Hemost; 2008 Feb; 34(1):58-73. PubMed ID: 18393143 [TBL] [Abstract][Full Text] [Related]
13. Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. Bick RL; Frenkel EP; Walenga J; Fareed J; Hoppensteadt DA Hematol Oncol Clin North Am; 2005 Feb; 19(1):1-51, v. PubMed ID: 15639107 [TBL] [Abstract][Full Text] [Related]
14. Unfractionated heparin versus low-molecular-weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients. Ang E Clin Nurse Spec; 2013; 27(5):229-30. PubMed ID: 23942101 [No Abstract] [Full Text] [Related]
15. So, does low-molecular-weight heparin cause less heparin-induced thrombocytopenia than unfractionated heparin or not? Warkentin TE; Greinacher A Chest; 2007 Oct; 132(4):1108-10. PubMed ID: 17934108 [No Abstract] [Full Text] [Related]
16. Do heparins do more than just treat thrombosis? The influence of heparins on cancer spread. Hettiarachchi RJ; Smorenburg SM; Ginsberg J; Levine M; Prins MH; Büller HR Thromb Haemost; 1999 Aug; 82(2):947-52. PubMed ID: 10605808 [No Abstract] [Full Text] [Related]
19. [Use of low-molecular-weight heparins in patients with prosthetic heart valves]. Hering D; Horstkotte D Dtsch Med Wochenschr; 2003 May; 128(20):1129-33. PubMed ID: 12748904 [No Abstract] [Full Text] [Related]
20. Role of heparin and low-molecular-weight heparins in the management of acute ischemic stroke. Padma V; Fisher M; Moonis M Expert Rev Cardiovasc Ther; 2006 May; 4(3):405-15. PubMed ID: 16716101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]